Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Transplantation
Open-data reference.
13 US clinical trials · 6 currently recruiting
Active & Recent Trials
Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation
University of Pennsylvania
NCT00457847
Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
University of Pennsylvania
NCT00552357
Trifecta-Lung cfDNA-MMDx Study
University of Alberta
NCT05837663
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
University of California, San Francis
NCT06853223
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Steven Hays, MD
NCT06018766
Transplanting Lungs From Uncontrolled Donation After Circulatory Death
NYU Langone Health
NCT06327945
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
TransMedics
NCT03639025
Inspiratory Muscle Training Immediately After Lung Transplantation
Ohio State University
NCT05309551
Rapid Detection of Airway Pathogens for Lung Transplantation
University of California, San Francis
NCT03933878
Lung Transplant G0 (LTGO): Improving Self-Management of Exercise After Lung Transplantation
University of Pittsburgh
NCT03728257
Lung Transplant Specimen Repository and Data Registry Protocol
Karen Wood
NCT00816257
Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study
University of Pittsburgh
NCT00177710
Intravenous Immunoglobulin (IVIG) in Lung Transplantation
Columbia University
NCT00115778
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Lung Transplantation Trial Landscape
ClinicalTrials.gov lists 13 US studies indexed under Lung Transplantation, and 6 of those are currently open to recruitment — roughly 46% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Lung Transplantation shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Lung Transplantation is led by University of Pittsburgh with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 13 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Lung Transplantation?
PlainTrial tracks 13 US clinical trials for Lung Transplantation, of which 6 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Lung Transplantation?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.